Improved survival in stage IB/II melanoma using Canvaxin™, a polyvalent cancer vaccine

被引：0
|
作者：
Faries, MB [1 ]
Foshag, LJ [1 ]
Essner, R [1 ]
Wanek, LA [1 ]
Morton, DL [1 ]
机构：
[1] John Wayne Canc Inst, Santa Monica, CA USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2005年 / 12卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S19 / S19
页数：1
相关论文
共 50 条
  • [41] Improved survival for stage IV melanoma from an unknown primary site
    Lee, C. C.
    Faries, M. B.
    Wanek, L. A.
    Morton, D. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [42] Adjuvant Autologous Melanoma Vaccine for Macroscopic Stage III Disease: Survival, Biomarkers, and Improved Response to CTLA-4 Blockade
    Lotem, Michal
    Merims, Sharon
    Frank, Stephen
    Hamburger, Tamar
    Nissan, Aviram
    Kadouri, Luna
    Cohen, Jonathan
    Straussman, Ravid
    Eisenberg, Galit
    Frankenburg, Shoshana
    Carmon, Einat
    Alaiyan, Bilal
    Shneibaum, Shlomo
    Ayyildiz, Zeynep Ozge
    Isbilen, Murat
    Senses, Kerem Mert
    Ron, Ilan
    Steinberg, Hanna
    Smith, Yoav
    Shiloni, Eitan
    Gure, Ali Osmay
    Peretz, Tamar
    JOURNAL OF IMMUNOLOGY RESEARCH, 2016, 2016
  • [43] Active specific immunotherapy with polyvalent melanoma cell vaccine (PMCV) in patients with in transit (UICC Stage N2b) melanoma metastases
    Nathanson, L
    Hsueh, EC
    Forhag, LJ
    Essner, R
    Nizze, JA
    Stern, SL
    Morton, DL
    17TH INTERNATIONAL CANCER CONGRESS, VOL 1 AND 2, 1998, : 439 - 443
  • [44] Micrometastases and survival in stage II colorectal cancer
    Liefers, GJ
    Cleton-Jansen, AM
    van de Velde, CJH
    Hermans, J
    van Krieken, JHJM
    Cornelisse, CJ
    Tollenaar, RAEM
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (04): : 223 - 228
  • [45] Modern Era Adjuvant Chemotherapy is associated with Improved Survival in Patients with Stage II Colon Cancer
    Casadaban, L.
    Aklilu, M.
    Villenes, D.
    Raucher, G.
    Freels, S.
    Maker, A. V.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S10 - S11
  • [46] Survival and Prognostic Factors Comparing Stage IB 1 versus Stage IB 2 Cervical Cancer Treated with Primary Radical Hysterectomy
    Srisomboon, Jatupol
    Kietpeerakool, Chumnan
    Suprasert, Prapaporn
    Manopanya, Manatsawee
    Siriaree, Sitthicha
    Charoenkwan, Kittipat
    Cheewakriangkrai, Chalong
    Sae-Teng, Charuwan
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2011, 12 (07) : 1753 - 1756
  • [47] Radical hysterectomy for stage IB cervical cancer: Recurrence interval as a predictor of survival
    Finan, MA
    Abdoh, AA
    Fiorica, JV
    Hoffman, MS
    Roberts, WS
    Cavanagh, D
    SOUTHERN MEDICAL JOURNAL, 1996, 89 (06) : 591 - 596
  • [48] Tumor angiogenesis in stage IB cervical cancer: Correlation of microvessel density with survival
    Obermair, A
    Wanner, C
    Bilgi, S
    Speiser, P
    Kaider, A
    Reinthaller, A
    Leodolter, S
    Gitsch, G
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1998, 178 (02) : 314 - 319
  • [49] Survival outcomes of Stage IB cervical cancer treated with standard radical hysterectomy
    Du, R.
    Li, L.
    Ma, S.
    Tan, X.
    Zhong, S.
    Wu, M.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2019, 40 (05) : 810 - 814
  • [50] RANDOMIZED, CONTROLLED-STUDY OF BESTATIN IN THE TREATMENT OF STAGE-IB AND STAGE-II MALIGNANT-MELANOMA
    IKEDA, S
    ISHIHARA, K
    INTERNATIONAL JOURNAL OF IMMUNOTHERAPY, 1986, 2 (01): : 73 - 79
12345